久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • MannKind and United Therapeutics NDA for Tyvaso DPI? Accepted by U.S. FDA americanpharmaceuticalreview
    June 18, 2021
    MannKind Corporation and United Therapeutics Corporation announced that the U.S. FDA accepted for priority review the New Drug Application (NDA) for Tyvaso DPI? (inhaled treprostinil) for the treatment of pulmonary arterial hypertension (PAH) and ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service